Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18294943rdf:typepubmed:Citationlld:pubmed
pubmed-article:18294943lifeskim:mentionsumls-concept:C0005972lld:lifeskim
pubmed-article:18294943lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:18294943pubmed:issue3lld:pubmed
pubmed-article:18294943pubmed:dateCreated2008-4-8lld:pubmed
pubmed-article:18294943pubmed:abstractTextMineralized collagen-glycosaminoglycan scaffolds designed for bone regeneration have been synthesized via triple co-precipitation in the absence of a titrant phase. Here, we characterize the microstructural and mechanical properties of these newly developed scaffolds with 50 and 75 wt.% mineral content. The 50 wt.% scaffold had an equiaxed pore structure with isotropic mechanical properties and a Ca-P-rich mineral phase comprised of brushite; the 75 wt.% scaffold had a bilayer structure with a pore size varying in the through-thickness direction and a mineral phase comprised of 67% brushite and 33 wt.% monetite. The compressive stress-strain response of the scaffolds was characteristic of low-density open-cell foams with distinct linear elastic, collapse plateau and densification regimes. The elastic modulus and strength of individual struts within the scaffolds were measured using an atomic force microscopy cantilevered beam-bending technique and compared with the composite response under indentation and unconfined compression. Cellular solids models, using the measured strut properties, overestimated the overall mechanical properties for the scaffolds; the discrepancy arises from defects such as disconnected pore walls within the scaffold. As the scaffold stiffness and strength decreased with increasing overall mineral content and were less than that of natural, mineralized collagen scaffolds, these microstructural/mechanical relations will be used to further improve scaffold design for bone regeneration applications.lld:pubmed
pubmed-article:18294943pubmed:languageenglld:pubmed
pubmed-article:18294943pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18294943pubmed:citationSubsetIMlld:pubmed
pubmed-article:18294943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18294943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18294943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18294943pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18294943pubmed:statusMEDLINElld:pubmed
pubmed-article:18294943pubmed:monthMaylld:pubmed
pubmed-article:18294943pubmed:issn1742-7061lld:pubmed
pubmed-article:18294943pubmed:authorpubmed-author:GibsonLorna...lld:pubmed
pubmed-article:18294943pubmed:authorpubmed-author:KanungoBiraja...lld:pubmed
pubmed-article:18294943pubmed:authorpubmed-author:SilvaEmilioElld:pubmed
pubmed-article:18294943pubmed:authorpubmed-author:Van...lld:pubmed
pubmed-article:18294943pubmed:issnTypePrintlld:pubmed
pubmed-article:18294943pubmed:volume4lld:pubmed
pubmed-article:18294943pubmed:ownerNLMlld:pubmed
pubmed-article:18294943pubmed:authorsCompleteYlld:pubmed
pubmed-article:18294943pubmed:pagination490-503lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:meshHeadingpubmed-meshheading:18294943...lld:pubmed
pubmed-article:18294943pubmed:year2008lld:pubmed
pubmed-article:18294943pubmed:articleTitleCharacterization of mineralized collagen-glycosaminoglycan scaffolds for bone regeneration.lld:pubmed
pubmed-article:18294943pubmed:affiliationDepartment of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.lld:pubmed
pubmed-article:18294943pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18294943pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18294943lld:pubmed